Axsome Therapeutics, Inc.
AXSM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001579428
In the last 90 days, Axsome Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 505 institutions reported holding it in 13F filings for Q2 2026, worth $9.34B in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Axsome Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 197 | 231 | +34 |
| Shares | 31.9M | 36.4M | +4.49M (+14.1%) |
| Value | $1.97B | $2.61B | +$647.0M (+32.9%) |
New holders (50)
Institutions that held Axsome Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (16)
Institutions that held Axsome Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Holocene Advisors, LP | 529,144 | $32.6M |
| ExodusPoint Capital Management, LP | 96,684 | $5.96M |
| Trexquant Investment LP | 22,732 | $1.40M |
| SG Americas Securities, LLC | 13,269 | $818.0K |
| Verition Fund Management LLC | 9,316 | $574.6K |
| Bayesian Capital Management, LP | 7,324 | $451.7K |
| Financial Consulate, Inc | 5,220 | $322.0K |
| Aquatic Capital Management LLC | 4,500 | $278.0K |
| Seven Eight Capital, LP | 3,819 | $235.6K |
| Blueshift Asset Management, LLC | 3,763 | $232.1K |
| Boulder Hill Capital Management LP | 3,300 | $203.5K |
| Cutler Group LP | 2,156 | $132.0K |
| Advisory Services Network, LLC | 1,333 | $82.2K |
| Dark Forest Capital Management LP | 825 | $50.9K |
| Tucker Asset Management LLC | 203 | $12.5K |
| TCI Wealth Advisors, Inc. | 108 | $6.66K |